About This Event
Join Children’s Hospital Association’s Benefit Advisory Services and EXL as we analyze Claims and Health Analytics Resource Tool (CHART®) data of over 9,000 members currently taking Glucagon-like Peptides (GLP-1) medication for weight loss.
According to the National Institute of Health, approximately 70% of U.S. adults are overweight and two-fifths are considered obese. GLP-1s are gaining popularity as a fast, effective solution to combat obesity.
Today, hospitals must evaluate the costs and benefits of covering high-cost prescriptions as a well-being or recruitment strategy.
In this webinar, we will explore CHART’s analysis of these key areas:
- Weight loss.
- Medication adherence.
- Differences in per member per month patterns between users and nonusers.
